Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€63.50
23.02.24
€75.68
23.02.25
13.39%
12.07.24

Needham & Company LLC 
23.02.24 50%
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€178.80
22.02.24
€191.27
22.02.25
-38.09%
08.07.24

Stifel Nicolaus 
22.02.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.65
22.02.24
€58.21
22.02.25
8.27%
12.07.24

Piper Sandler 
22.02.24 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.24
22.02.24
€13.86
22.02.25
-40.08%
26.06.24

HC Wainwright 
22.02.24 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€41.40
22.02.24
€46.19
22.02.25
10.63%
12.07.24

Needham & Company LLC 
22.02.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.78
22.02.24
€83.21
22.02.25
-1.80%
12.07.24

Mizuho 
22.02.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€205.20
22.02.24
€256.09
22.02.25
2.83%
12.07.24

Mizuho 
22.02.24 50%
buy
Exact Sciences

Start price
Target price
Perf. (%)
€56.50
22.02.24
-
22.02.25
-24.73%
12.07.24

William Blair 
22.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€202.00
22.02.24
€277.11
22.02.25
45.94%
12.07.24

HC Wainwright 
22.02.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.10
22.02.24
€55.42
22.02.25
9.75%
12.07.24

Needham & Company LLC 
22.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€202.00
22.02.24
€284.50
22.02.25
45.94%
12.07.24

Wedbush 
22.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€138.00
21.02.24
-
21.02.25
73.19%
12.07.24

StockNews.com 
21.02.24 50%
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€23.40
21.02.24
€46.24
21.02.25
17.95%
11.07.24

Stifel Nicolaus 
21.02.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.80
21.02.24
€46.24
21.02.25
36.26%
12.07.24

HC Wainwright 
21.02.24 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.08
21.02.24
-
21.02.25
-61.37%
12.07.24

Fitzi 
21.02.24 0%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€387.20
20.02.24
€406.87
20.02.25
15.74%
12.07.24

Cantor Fitzgerald 
20.02.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€699.00
20.02.24
€753.63
20.02.25
24.63%
12.07.24

Cantor Fitzgerald 
20.02.24 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€146.10
20.02.24
€198.81
20.02.25
-5.12%
12.07.24

Cantor Fitzgerald 
20.02.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€200.60
20.02.24
€287.58
20.02.25
5.18%
12.07.24

Cantor Fitzgerald 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
20.02.24
€20.35
20.02.25
-31.62%
12.07.24

Wells Fargo & Company 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€17.55
20.02.25
-32.20%
12.07.24

The Goldman Sachs Group, Inc. 
20.02.24 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€173.95
20.02.24
€203.21
20.02.25
-5.37%
12.07.24

Piper Sandler 
20.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.40
20.02.24
€217.07
20.02.25
73.94%
12.07.24

Royal Bank of Canada 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€16.63
20.02.25
-32.20%
12.07.24

Piper Sandler 
20.02.24 50%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€25.20
20.02.24
€73.90
20.02.25
-18.25%
11.07.24

Oppenheimer Holdings Inc. 
20.02.24 50%